Home

Suven Pharmaceuticals Ltd Quarterly Result

Image

Suven Pharmaceuticals Ltd

NSE: SUVENPHAR

Net Profit - Last Quarter

₹ 81.98 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Suven Pharmaceuticals Ltd for the Sep '24 is ₹ 271.84 crore as compare to the Jun '24 revenue of ₹ 248.85 crore. This represent the growth of 9.238493%.
  • The ebitda of Suven Pharmaceuticals Ltd for the Sep '24 is ₹ 118.13 crore as compare to the Jun '24 ebitda of ₹ 98.09 crore. This represent the growth of 20.43022%.
  • The net profit of Suven Pharmaceuticals Ltd for the Sep '24 is ₹ 81.98 crore as compare to the Jun '24 net profit of ₹ 60.77 crore. This represent the growth of 34.902092%.

Results Analysis

Market Price of Suven Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Suven Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 20251055.15
14 Jan 20251054.75
13 Jan 20251049.95
10 Jan 20251061.9
09 Jan 20251103.55
08 Jan 20251102.1
07 Jan 20251092.8
06 Jan 20251092.2
03 Jan 20251105.75
02 Jan 20251114.4

Historical Revenue of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Suven Pharmaceuticals Ltd News Hub

Suven Pharmaceuticals consolidated net profit declines 49.61% in the June 2024 quarter

Net profit of Suven Pharmaceuticals declined 49.61% to Rs 60.77 crore in the quarter ended June 2024

Read more

09 Aug 2024

Suven Pharmaceuticals to hold board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 August 2024.

Read more

06 Aug 2024

Suven Pharmaceuticals appoints Vivek Sharma as new Executive Chairman

Suven Pharmaceuticals announced the appointment of Vivek Sharma as the new Executive Chairman, effec

Read more

19 Sep 2024

Board of Suven Pharmaceuticals approves change in Executive Chairperson

The Board of Suven Pharmaceuticals at its meeting held on 19 September 2024 has taken on record the

Read more

19 Sep 2024

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

June 2024

TranscriptPPT

June 2023

TranscriptPPT

Feb 2023

Transcript

Dec 2022

Transcript

Nov 2022

Transcript

June 2022

Transcript

Feb 2022

PPT

Nov 2021

PPT

Aug 2021

PPT

June 2021

TranscriptPPT

FAQs for Quarterly Results of Suven Pharmaceuticals Ltd

What key financial metrics are included in Suven Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Suven Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Suven Pharmaceuticals Ltd announce its quarterly results?

Suven Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Suven Pharmaceuticals Ltd's quarterly performance impact its stock price?

Suven Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Suven Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Suven Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Suven Pharmaceuticals Ltd's quarterly results?

Yes, Suven Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions